Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2014

01-11-2014 | Erratum

Erratum to: Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells

Authors: Aleksandra Filipović, Ylenia Lombardo, Monica Faronato, Joel Abrahams, Eric Aboagye, Quang-De Nguyen, Barbara Borda d’Aqua, Anne Ridley, Andrew Green, Emad Rahka, Ian Ellis, Chiara Recchi, Natasa Przulj, Anida Sarajlić, Jean-Rene Alattia, Patrick Fraering, Mahendra Deonarain, R. Charles Coombes

Published in: Breast Cancer Research and Treatment | Issue 2/2014

Login to get access

Excerpt

In the original publication, the last name of the third author has been misspelt. The authors’ apologize for this error. The correct name of the third author appears in this erratum. …
Metadata
Title
Erratum to: Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells
Authors
Aleksandra Filipović
Ylenia Lombardo
Monica Faronato
Joel Abrahams
Eric Aboagye
Quang-De Nguyen
Barbara Borda d’Aqua
Anne Ridley
Andrew Green
Emad Rahka
Ian Ellis
Chiara Recchi
Natasa Przulj
Anida Sarajlić
Jean-Rene Alattia
Patrick Fraering
Mahendra Deonarain
R. Charles Coombes
Publication date
01-11-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3174-5

Other articles of this Issue 2/2014

Breast Cancer Research and Treatment 2/2014 Go to the issue

Brief Report

Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells

Letter to the Editor

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine: rule of thumb in prediction studies

Brief Report

Upper extremity bioimpedance before and after treadmill testing in women post breast cancer treatment

Preclinical study

Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo

Epidemiology

Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias

Epidemiology

Metabolic syndrome and outcomes following early-stage breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits